Shukra Pharmaceuticals Ltd

Shukra Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Shukra Pharmaceuticals Ltd

₹ 31.7 -1.86%
24 Jul - close price
shukrapharmaceuticals.com BSE: 524632
About

Incorporated in 1993, Shukra Pharmaceuticals Ltd manufactures and markets pharmaceutical products, and does laboratory testing[1]

Key Points

Business Overview:[1][2]
SPL is a is WHO-GMP certified integrated manufacturer of formulations like tablet, capsules and small volume parenteral. It has assisted in the development and manufacture
of a variety of drugs and dosage forms and potency variations for many pharmaceutical companies

Website BSE
  • Market Cap ₹ 1,389 Cr.
  • Current Price ₹ 31.7
  • High / Low ₹ 65.3 / 17.1
  • Stock P/E 63.0
  • Book Value ₹ 2.05
  • Dividend Yield 0.03 %
  • ROCE 36.9 %
  • ROE 28.9 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 175% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.2%

Cons

  • Stock is trading at 15.5 times its book value
  • Debtor days have increased from 122 to 148 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
46.25 20.16 24.64 18.89 10.88 3.18 5.56 10.58 13.27 5.39 5.88 39.13 6.30
42.60 19.82 19.55 9.34 6.45 2.38 4.90 6.65 5.96 4.07 6.29 12.00 5.61
Operating Profit 3.65 0.34 5.09 9.55 4.43 0.80 0.66 3.93 7.31 1.32 -0.41 27.13 0.69
OPM % 7.89% 1.69% 20.66% 50.56% 40.72% 25.16% 11.87% 37.15% 55.09% 24.49% -6.97% 69.33% 10.95%
0.89 0.63 0.24 0.56 1.38 0.72 1.02 1.01 1.47 1.11 1.71 0.82 0.95
Interest 0.07 0.08 0.06 0.07 0.07 0.06 0.11 0.15 0.27 0.27 0.29 0.28 0.26
Depreciation 0.51 0.46 0.56 0.51 0.52 0.67 0.70 0.70 0.94 0.79 0.81 0.84 1.01
Profit before tax 3.96 0.43 4.71 9.53 5.22 0.79 0.87 4.09 7.57 1.37 0.20 26.83 0.37
Tax % -0.25% 2.33% -0.21% 1.05% 23.75% 40.51% 39.08% 22.74% 28.80% 25.55% -1,090.00% 24.08% 567.57%
3.98 0.42 4.71 9.42 3.99 0.49 0.54 3.16 5.39 1.03 2.38 20.36 -1.73
EPS in Rs 0.09 0.01 0.11 0.22 0.09 0.01 0.01 0.07 0.12 0.02 0.05 0.46 -0.04
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
3 5 5 5 6 12 11 20 59 75 33 57
3 4 4 4 4 10 10 18 53 55 20 28
Operating Profit -0 1 1 2 2 2 1 3 5 19 13 29
OPM % -10% 24% 28% 30% 29% 13% 13% 14% 9% 26% 39% 51%
1 -0 0 0 0 0 0 0 1 3 4 5
Interest 0 0 0 0 0 0 0 0 0 0 1 1
Depreciation 1 0 0 1 1 1 1 2 2 2 3 3
Profit before tax 0 0 1 1 1 0 0 1 4 20 13 29
Tax % 52% 66% 52% 45% 37% 82% -90% 26% 1% 7% 28% 23%
0 0 0 1 0 0 0 1 4 19 10 22
EPS in Rs 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.02 0.10 0.42 0.22 0.50
Dividend Payout % 0% 0% 16% 15% 17% 0% 0% 10% 4% 6% 5% 2%
Compounded Sales Growth
10 Years: 28%
5 Years: 38%
3 Years: -1%
TTM: 74%
Compounded Profit Growth
10 Years: 53%
5 Years: 175%
3 Years: 71%
TTM: 130%
Stock Price CAGR
10 Years: 57%
5 Years: 151%
3 Years: 107%
1 Year: 63%
Return on Equity
10 Years: 20%
5 Years: 26%
3 Years: 28%
Last Year: 29%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 2 2 2 2 2 2 2 2 4 11 44 44
Reserves 12 13 13 13 14 14 14 15 21 47 19 46
1 0 0 4 6 8 10 3 5 3 4 5
3 3 4 6 7 10 10 15 45 17 20 23
Total Liabilities 18 17 19 24 28 34 36 35 75 78 87 117
10 10 10 14 16 17 18 18 20 20 19 22
CWIP 2 2 2 2 2 2 2 2 2 2 2 12
Investments 0 0 0 0 0 0 0 0 0 0 0 0
7 6 7 8 11 14 16 16 53 56 65 84
Total Assets 18 17 19 24 28 34 36 35 75 78 87 117

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-2 3 -0 1 0 1 1 8 3 -5 8 3
1 -0 -1 -5 -2 -3 -2 -2 -4 -1 -1 -14
1 -1 0 3 2 2 2 -7 5 12 -5 5
Net Cash Flow 0 1 -1 -0 0 -0 0 -0 4 6 2 -6
Free Cash Flow -1 2 -1 -4 -2 -2 -1 6 -1 -7 5 -13
CFO/OP 812% 237% 7% 63% 25% 81% 38% 292% 64% -24% 92% 17%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 73 71 175 200 345 245 318 132 187 120 98 148
Inventory Days 554 92 112 53 100 169 221 139 25 19 447 320
Days Payable 291 108 400 734 1,161 786 702 303 271 59 414 232
Cash Conversion Cycle 335 54 -112 -480 -717 -372 -163 -32 -58 80 131 236
Working Capital Days 758 258 344 379 440 226 278 57 41 157 404 352
ROCE % -1% 6% 7% 6% 4% 0% 1% 6% 19% 44% 22% 37%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Revenue share - Commission Income (Other Operating Revenues)
% of revenue from operations

Log in to view insights

Please log in to see hidden values.

Login
Revenue share - Sale of Products (Manufacturing)
% of revenue from operations
Revenue share - Sale of Services (Jobwork/Contract Manufacturing)
% of revenue from operations
Revenue share - Sale of Trading (Traded goods)
% of revenue from operations
Permanent employees on rolls
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
50.90% 50.95% 50.95% 50.95% 50.95% 50.95% 50.95% 50.95% 50.95% 50.95% 50.95% 50.95%
0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11%
48.99% 48.93% 48.93% 48.93% 48.93% 48.93% 48.93% 48.93% 48.93% 48.93% 48.92% 48.93%
No. of Shareholders 9,74710,96312,97414,98916,32117,84418,23120,33721,44125,64927,17328,384

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports